It is classified as a research chemical, meaning: It cannot be legally marketed as a drug or supplement It is not recognized as "Generally Recognized as Safe" (GRAS) No New Drug Application (NDA) has been submitted It has not undergone the formal FDA approval process Research Chemical Status BPC-157 is available for purchase as a "research chemical" in most jurisdictions, with important caveats: Sold for "research purposes only" Not for human consumption (legally) No quality standards enforced by regulatory agencies Purity and identity depend entirely on supplier integrity International Regulations Regulatory status varies by country: United States : Research chemical, not approved for human use European Union : Not approved, status varies by member state Canada : Not approved for human use, research chemical Australia : Not approved, TGA Category 4 substance United Kingdom : Not approved for human use Sports and Competition BPC-157 is not specifically listed on the World Anti-Doping Agency (WADA) prohibited list, unlike TB-500
What we found Our analysis of semaglutide, tirzepatide, and pembrolizumab included 575 shipments in total
However, as with any comprehensive supplement protocol for complex chronic illness, it is imperative to work closely with a knowledgeable healthcare provider who can tailor the approach to your specific biochemical needs and monitor for any unexpected reactions
DAI senses influenza A virus genomic RNA and activates RIPK3-dependent cell death
Accessed 17 Mar 2024 Nickel KF, Long AT, Fuchs TA et al (2017) Factor XII as a therapeutic target in thromboembolic and inflammatory diseases
